Explore the latest in law and medicine, including malpractice, regulation, and legislation affecting public health and clinical practice.
This Viewpoint offers potential changes to improve the process of US Food and Drug Administration accelerated approval.
This Viewpoint explains how “skinny labeling” works (bioequivalent drugs approved for unpatented uses and excluding patented indications from the generic drug’s labeling), the uncertainty about this pathway, and how the government and generic manufacturers can help restore timely generic competition in the face of brand-name drugs protected by patents.
This quasi-experimental study examines whether litigation is associated with reductions in homophobic bullying among students in California high schools.
This cross-sectional study identifies the number and class of drugs approved through the US Food and Drug Administration’s accelerated approval pathway and analyzes state Medicaid programs’ use and spending on these drugs from 2015 through 2019.
This Viewpoint discusses the US Food and Drug Administration’s accelerated approval pathway and proposes the need for reforms as well as the timely completion of postapproval trials.
This economic analysis examines more than 2.5 million insurance claims for anesthesia services paid to in- and out-of-network practitioners before and after surprise-billing legislation was passed in California, Florida, and New York.
This cross-sectional study examines whether the implementation of mandated consultation with a prescription drug monitoring program was associated with changes in the quantity of postoperative opioid medications prescribed at discharge among adult patients in a health care system in California.
This Viewpoint describes evolving legislation and technology needs for ensuring appropriate medical information is shared with or blocked from pediatric patients and their proxies.
This Viewpoint discusses ethical considerations and use of patents for human germline editing in the context of a recent World Health Organization report and release of several auxiliary documents exploring international governance tools for human genome engineering.
This Special Communication provides a legal analysis of whether the First Amendment prohibits the US Food and Drug Administration’s requirement of new tobacco warning labels.
This Viewpoint discusses SB8, the recent law passed in Texas that essentially prohibits abortion after 6 weeks of gestational age, and the effect this will have on persons seeking pregnancy termination as well as the future of constitutional protection of abortion services.
This cross-sectional study compares the prevalence of third-party data tracking on websites of the largest and top-rated nonprofit and for-profit hospitals in the US.
This Viewpoint discusses escalating and organized efforts throughout the United States to curtail gender-affirming care for transgender adolescents.
This Viewpoint discusses the continuing physical and financial effects of the 1976 Hyde Amendment (as subsequently revised) curtailing access to abortion services for low-income US citizens and examines the risks posed by this and similar legislation.
This cross-sectional study examines the proportion of US nonprofit hospitals with community health needs assessments and implementation strategies as required by the Patient Protection and Affordable Care Act.
This Viewpoint reviews legalization initiatives for psychedelic substances and the concerns they raise by looking to the cautionary precedents involving the legalization and commercialization of other controlled substances.
This cross-sectional study evaluates the association of a research publication describing hospital lawsuits filed against patients for unpaid medical bills and the prevalence of this practice among hospitals in Virginia.
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: